Multiple COVID-19 vaccines have been developed within the past year and found to be safe and effective, stated GAVI, the Vaccine Alliance, on May 14, 2021.
These achievements have been followed by a massive effort to scale up the manufacturing of the innovative COVID-19 vaccines. Production output is posed to exceed 10 billion COVID-19 vaccine doses by the end of 2021.
Task Force to Tackle COVID-19 Vaccine Supply Challenges
New Guidance for Evaluating Prevention and Treatment Options for COVID-19
The U.S. Food and Drug Administration issued final guidance today entitled, “COVID-19: Master Protocols Evaluating Drugs and Biological Products for Treatment or Prevention Guidance for Industry.”
This guidance describes the FDA’s current recommendations to sponsors of master protocols evaluating drugs to treat or prevent COVID-19.
Environmental perspective of COVID-19: Atmospheric and wastewater environment in relation to pandemic.
The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major challenge to health systems worldwide. Recently, numbers of epidemiological studies have […]
Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study.
Hematological comparison of coronavirus disease (COVID-19) and other viral pneumonias can provide insights into COVID-19 treatment.In this retrospective case-control single-center study, we compared the data of 126 patients with viral […]
Post COVID-19 Vaccine Related Shingles Cases seen at the Las Vegas Dermatology Clinic and sent to us via Social Media.
On March 11th 2020, the World Health Organization declared COVID-19 a global pandemic. COVID-19 is a novel coronavirus with high infectivity and severe morbidity and mortality, especially for those over […]
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia.
Remdesivir is one of the most encouraging treatments against SARS-CoV-2 infection. After intravenous infusion, RDV is rapidly metabolized (T1/2 1h) within the cells to its active adenosine triphosphate analogue form […]
Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
SARS-CoV-2 uptake by lung epithelial cells is a critical step in the pathogenesis of COVID-19. Viral entry is dependent on the binding of the viral spike protein to the angiotensin […]
covid19census: U.S. and Italy COVID-19 metrics and other epidemiological data.
Since the beginning of the coronavirus disease-2019 (COVID-19) pandemic in 2020, there has been a tremendous accumulation of data capturing different statistics including the number of tests, confirmed cases and […]
First Report of SARS-CoV-2 Detection in Cerebrospinal Fluid in a Child With Guillain-Barré Syndrome.
Underlying mechanisms on the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and neurological complications are still poorly understood. Cases of Guillain-Barré Syndrome (GBS) have been linked to […]
Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain.
Infections are one of the well-known precipitating factors for relapses in patients with immune thrombocytopenia (ITP). Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can sometimes lead to or be associated […]